Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority TrialJi-Jung Jung, Han‐Byoel Lee, Sung Gwe Ahn et al.|Journal of Breast Cancer|2024Cited by 26
Omission of breast surgery for predicted pCR patients with MRI and vacuum-assisted biopsy in breast cancer after neoadjuvant chemotherapy: A multicenter, single-arm, non-inferiority trial (OPTIMIST trial).Ji-Jung Jung, Soo‐Yeon Kim, Jiwon Koh et al.|Journal of Clinical Oncology|2023Cited by 7
Abstract 912: CheckpointPx, an interpretable radiology AI tool, predicts checkpoint blockade benefit independent of PDL1 status in non-small cell lung cancers (NSCLC): A multi-institutional validation studyAmogh Hiremath, Young Kwang Chae, Seyoung Lee et al.|Cancer Research|2024Cited by 2
Prognostic Performance of the Next-Generation Sequencing-Based Multigene Assay in Early Breast Cancer Patients Treated According to the 21-Gene Assay ResultsEunhye Kang, Jai Min Ryu, Jong-Ho Cheun et al.|Cancer Research and Treatment|2024Cited by 2